STEMI - ST Elevation Myocardial Infarction (MI)

2

Review clinical trials related to STEMI - ST Elevation Myocardial Infarction (MI). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Prognostic Value of the LVOT VTI in STEMI Patients Undergoing PPCI

* To determine whether LVOT VTI \< 15 cm predicts the development of in-hospital cardiogenic shock or need for vasopressors in STEMI patients undergoing primary PCI. * To assess association of LVOT VTI with other adverse outcomes (in-hospital death, heart failure, arrhythmias, need for mechanical ventilation, prolonged hospital stay).

Participants needed: 125
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Assiut UniversityUpdated: Aug 11, 2025Locations: 1
Eligibility criteria

Adult patients (≥18 years), diagnosed with acute STEMI according to current ESC... [+1]

Presence of significant aortic valve disease (e.g., severe aortic stenosis or re... [+3]

Status: Not yet recruiting

Assessment of Prognosis and Myocardial Reperfusion in Patients with ST-segment-elevation Myocardial Infarction (STEMI) According to Coronary Atherosclerotic Burden.

In the current literature, it has been widely demonstrated that the extend of coronary atherosclerotic burden is associated with adverse long-term outcomes. Little is known about the impact of atheroma burden and either myocardial reperfusion and short-term outcomes after ST-segment elevation myocardial infarction (STEMI). Several angiographic scores have been used to measure the extend and severity of coronary atheroma. The SYNTAX score and the Gensini score have been shown to be independent predictors of cardiovascular events and mortality in stable coronary artery disease as well as in myocardial infarction. This research therefore aims to assess the impact of overall coronary atherosclerotic burden, measured by two angiographic scores (SYNTAX score and Gensini score), both before and after primary percutaneous angioplasty, in patients with STEMI according to different clinical subgroups.

Participants needed: 2,200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Central Hospital, Nancy, FranceUpdated: Mar 14, 2025
Eligibility criteria

Not listed